P2 receptors in renal autoregulation

Current Vascular Pharmacology

Volumn 12, Issue 6, 2014, Pages 818-828

  Guan, Zhengrong ^a   Fellner, Robert C ^a   Van Beusecum, Justin ^a   Inscho, Edward W ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Adenosine; Afferent arterioles; ATP; Connexins; Myogenic behavior; P2 receptors; Tubuloglomerular feedback

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE TRIPHOSPHATE; CYCLIC AMP; PURINERGIC P2 RECEPTOR; RHO KINASE;

ARTICLE; AUTOREGULATION; ELECTROLYTE BALANCE; ENZYME ACTIVITY; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INFLAMMATION; KIDNEY BLOOD FLOW; PERFUSION PRESSURE; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; VASCULAR RESISTANCE; ANIMAL; HOMEOSTASIS; KIDNEY; KIDNEY CIRCULATION; METABOLISM; PHYSIOLOGY; SECRETION (PROCESS); VASCULAR SMOOTH MUSCLE; VASCULARIZATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; GLOMERULAR FILTRATION RATE; HOMEOSTASIS; HUMANS; KIDNEY; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, PURINERGIC P2; RENAL CIRCULATION;

EID: 84921493409     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/15701611113116660152     Document Type: Article

References (124)

1. Navar LG, Inscho EW, Majid DSA, Imig JD, Harrison-Bernard LM, Mitchell KD. Paracrine regulation of the renal microcirculation. Physiol Rev 1996; 76: 425-536.
2. Carmines PK, Inscho EW, Gensure RC. Arterial pressure effects on preglomerular microvasculature of juxtamedullary nephrons. Am J Physiol 1990; 258: F94-F102.
3. Davis MJ, Hill MA. Signaling mechanisms underlying the vascular myogenic response. Physiol Rev 1999; 79: 387-423.
4. Bidani AK, Griffin KA. Pathophysiology of hypertensive renal damage: Implications for therapy. Hypertension 2004; 44: 595-601.
5. Palmer BF. Disturbances in renal autoregulation and the susceptibility to hypertension-induced chronic kidney disease. Am J Med Sci 2004; 328: 330-48.
6. Savoia C, Schiffrin EL. Vascular inflammation in hypertension and diabetes: Molecular mechanisms and therapeutic interventions. Clin Sci 2007; 112: 375-84.
7. Parmer RJ, Stone RA, Cervenka JH. Renal hemodynamics in essential hypertension. Racial differences in response to changes in dietary sodium. Hypertension 1994; 24: 752-7.
8. Kotchen TA, Piering AW, Cowley AW, et al. Glomerular hyperfiltration in hypertensive African Americans. Hypertension 2000; 35: 822-6.
9. Griffin KA, Bidani A.: Hypertensive renal damage: Insights from animal models and clinical relevance. Curr Hypertension Rep 2004; 6: 145-53.
10. Hill GS. Hypertensive nephrosclerosis. Curr Opin Nephrol Hypertension 2008; 17: 266-70.
11. Feldberg R, Colding-Jorgensen M, Holstein-Rathlou N-H. Analysis of interaction between TGF and the myogenic response in renal blood flow autoregulation. Am J Physiol 1995; 269: F581-F593.
12. Navar LG, Inscho EW, Imig JD, Mitchell KD. Heterogeneous activation mechanisms in the renal microvasculature. Kidney Int 1998; 54: S17-S21.
13. Just A. Mechanisms of renal blood flow autoregulation: dynamics and contributions. Am J Physiol Regul Integr Comp Physiol 2007; 292: R1-17.
14. Schnermann J, Briggs JP.: Tubuloglomerular feedback: Mechanistic insights from gene-manipulated mice. Kidney Int 2008; 74: 418-26.
15. Von Kügelgen I, Harden TK. Molecular pharmacology, physiology, and structure of the P2Y receptors. Adv Pharmacol 2011; 61: 373-415.
16. Surprenant A, North RA. Signaling at purinergic P2X receptors. Ann Rev Physiol 2009; 71: 333-59.
17. Miyata N, Roman RJ. Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system. J Smooth Muscle Res 2005; 41: 175-93.
18. Unwin RJ, Bailey MA, Burnstock G. Purinergic signaling along the renal tubule: The current state of play. News Physiol Sci 2003; 18: 237-41.
19. Casellas D, Carmines PK. Control of the renal microcirculation: Cellular and integrative perspectives. Curr Opin Nephrol Hypertension 1996; 5: 57-63.
20. Hayashi K, Epstein M, Loutzenhiser R. Pressure-induced vasoconstriction of renal microvessels in normotensive and hypertensive rats: Studies in the isolated perfused hydronephrotic kidney. Circ Res 1989; 65: 1475-84.
21. Inscho EW. P2 receptors in the regulation of renal microvascular function. Am J Physiol Renal Physiol 2001; 280: F927-F944.
22. Guan Z, Osmond DA, Inscho EW. P2X receptors as regulators of the renal microvasculature. Trends Pharmacol Sci 2007; 28: 646-52.
23. White SM, Imig JD, Inscho EW. Calcium signaling pathways utilized by P2X receptors in preglomerular vascular smooth muscle cells. Am J Physiol Renal Physiol 2001; 280: F1054-F1061.
24. Hasko G, Linden J, Cronstein B, Pacher P. Adenosine receptors: Therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 2008; 7: 759-70.
25. Martinka P, Lai EY, Fahling M, et al. Adenosine increases calcium sensitivity via receptor-independent activation of the p38/MK2 pathway in mesenteric arteries. Acta Physiol 2008; 193: 37-46.
26. Inscho EW, Cook AK, Imig JD, Vial C, Evans RJ. Physiological role for P2X1 receptors in renal microvascular autoregulatory behavior. J Clin Invest 2003; 112: 1895-905.
27. Randriamboavonjy V, Busse R, Fleming I. 20-HETE-induced contraction of small coronary arteries depends on the activation of rho-kinase. Hypertension 2003; 41: 801-6.
28. Kaley G. Regulation of vascular tone-Role of 20-HETE in the modulation of myogenic reactivity. Circ Res 2000; 87: 4-5.
29. Imig JD, Falck JR, Gebremedhin D, Harder DR, Roman RJ. Elevated renovascular tone in young spontaneously hypertensive rats: Role of cytochrome P-450. Hypertension 1993; 22: 357-64.
30. Zhao X, Falck JR, Gopal VR, Inscho EW, Imig JD. P2X receptorstimulated calcium responses in preglomerular vascular smooth muscle cells involves 20-hydroxyeicosatetraenoic acid. J Pharmacol Exp Ther 2004; 311: 1211-7.
31. Gebremedhin D, Lange AR, Lowry TF, et al. Production of 20-HETE and its role in autoregulation of cerebral blood flow. Circ Res 2000; 87: 60-5.
32. Schubert R, Kalentchuk VU, Krien U. Rho kinase inhibition partly weakens myogenic reactivity in rat small arteries by changing calcium sensitivity. Am J Physiol Heart Circ Physiol 2002; 283: H2288-H2295.
33. Ito S, Kume H, Honjo H, et al. Possible involvement of Rho kinase in Ca2+ sensitization and mobilization by MCh in tracheal smooth muscle. Am J Physiol Lung Cell Mol Physiol 2001; 280: L1218-L1224.
34. Nakamura A, Hayashi K, Ozawa Y, et al. Vessel-and vasoconstrictor-dependent role of rho/rho-kinase in renal microvascular tone. J Vasc Res 2003; 40: 244-51.
35. Inscho EW, Cook AK, Webb RC, Jin LM. Rho-kinase inhibition reduces pressure-mediated autoregulatory adjustments in afferent arteriolar diameter. Am J Physiol Renal Physiol 2009; 296: F590-F597.
36. Sharma K, Cook A, Smith M, Valancius C, Inscho EW. TGF-β impairs renal autoregulation via generation of ROS. Am J Physiol Renal Fluid Electrolyte Physiol 2005; 288: F1069-F1077.
37. Lai EY, Wellstein A, Welch WJ, Wilcox CS. Superoxide modulates myogenic contractions of mouse afferent arterioles. Hypertension 2011; 58: 650-6.
38. Verney EB, Starling EH. On secretion by the isolated kidney. J Physiol (Lond) 1922; 56: 353-8.
39. Shipley RE, Study RS. Changes in renal blood flow, extraction of inulin, glomerular filtration rate, tissue pressure and urine flow with acute alterations of renal artery blood pressure. Am J Physiol 1951; 167: 676-88.
40. Navar LG, Inscho EW, Ibarrola AM, Carmines PK. Communication between the macula densa cells and the afferent arteriole. Kidney Int 1991; 39(Suppl 32): S78-S82.
41. Ren Y, Garvin J, Liu R, Carretero O. Cross-talk between arterioles and tubules in the kidney. Ped Nephrol 2009; 24: 31.
42. Just A, Arendshorst WJ. A novel mechanism of renal blood flow autoregulation and the autoregulatory role of A1 adenosine receptors in mice. Am J Physiol Renal Physiol 2007; 293: F1489-F1500.
43. Inscho EW, Cook AK, Navar LG. Pressure-mediated vasoconstriction of juxtamedullary afferent arterioles involves P2-purinoceptor activation. Am J Physiol Renal,Fluid Electrolyte Physiol 1996; 271: F1077-F1085.
44. Inscho EW, Carmines PK, Cook AK, Navar LG. Afferent arteriolar responsiveness to altered perfusion pressure in renal hypertension. Hypertension 1990; 15: 748-52.
45. Inscho EW, Imig JD, Deichmann PC, Cook AK. Candesartancilexetil protects against loss of autoregulatory efficiency in angiotensin II infused rats. J Am Soc Nephrol 1999; 10: S178-S183.
46. Inscho EW, Cook AK, Murzynowski J, Imig JD. Elevated arterial pressure impairs autoregulation independently of AT1 receptors. J Hypertens 2004; 22: 811-8.
47. Inscho EW, Cook AK, Imig JD, Vial C, Evans RJ. Renal autoregulation in P2X1 knockout mice. Acta Physiol Scand 2004; 181: 445-53.
48. Schnermann J, Levine DZ. Paracrine factors in tubuloglomerular feedback: Adenosine, ATP and nitric oxide. Ann Rev Physiol 2003; 65: 501-29.
49. Hashimoto S, Huang Y, Briggs J, Schnermann J. Reduced autoregulatory effectiveness in adenosine 1 receptor-deficient mice. Am J Physiol Renal Physiol 2006; 290: F888-F891.
50. Sun D, Samuelson LC, Yang T, et al. Mediation of tubuloglomerular feedback by adenosine: Evidence from mice lacking adenosine A1 receptors. Proc Natl Acad Sci USA 2001; 98: 9983-8.
51. Traynor T, Yang TX, Huang YG, et al. Inhibition of adenosine-1 receptor-mediated preglomerular vasoconstriction in AT1A receptor-deficient mice. Am J Physiol Renal Physiol 1998; 275: F922-F927.
52. Castrop H, Huang Y, Hashimoto S, et al. Impairment of tubuloglomerular feedback regulation of GFR in ecto-5'-nucleotidase/CD73–deficient mice. J Clin Invest 2004; 114: 634-42.
53. Ibarrola AM, Inscho EW, Vari RC, Navar LG. Influence of adenosine receptor blockade on renal function and autoregulation. J Am Soc Nephrol 1991; 2: 991-9.
54. Osmond DA, Inscho EW. P2X1 receptor blockade inhibits whole kidney autoregulation of renal blood flow in vivo. Am J Physiol Renal Physiol 2010; 298: F1360-F1368.
55. Jernigan NL, Drummond HA. Myogenic vasoconstriction in mouse renal interlobar arteries: role of endogenous beta and {gamma}ENaC. Am J Physiol Renal Physiol 2006; 291: F1184-F1191.
56. Wang X, Takeya K, Aaronson PI, Loutzenhiser K, Loutzenhiser R. Effects of amiloride, benzamil, and alterations in extracellular Na+ on the rat afferent arteriole and its myogenic response. Am J Physiol Renal Physiol 2008; 295: F272-F282.
57. Guan Z, Pollock JS, Cook AK, Hobbs J, Inscho EW. Effect of epithelial sodium channel (ENaC) blockade on the myogenic response of rat juxtamedullary afferent arterioles. Hypertension 2009; 54: 1062-9.
58. Ge Y, Gannon K, Gousset M, Liu R, Murphey B, Drummond HA. Impaired myogenic constriction of the renal afferent arteriole in a mouse model of reduced β ENaC expression. Am J Physiol Renal Physiol 2012; 302: F1486-F1493.
59. Grifoni SC, Chiposi R, McKey SE, Ryan MJ, Drummond HA. Altered whole kidney blood flow autoregulation in a mouse model of reduced β-ENaC. Am J Physiol Renal Physiol 2010; 298: F285-F292.
60. Peti-Peterdi J. Calcium wave of tubuloglomerular feedback. Am J Physiol Renal Physiol 2006; 291: F473-F480.
61. Toma I, Bansal E, Meer EJ, Kang JJ, Vargas SL, Peti-Peterdi J. Connexin 40 and ATP-dependent intercellular calcium wave in renal glomerular endothelial cells. Am J Physiol Regul Integr Comp Physiol 2008; 294: R1769-R1776.
62. Hanner F, Lam L, Nguyen MTX, Yu A, Peti-Peterdi J. Intrarenal localization of the plasma membrane ATP channel pannexin1. Am J Physiol Renal Physiol 2012; 303: F1454-F1459.
63. Bao L, Locovei S, Dahl G. Pannexin membrane channels are mechanosensitive conduits for ATP. FEBS Letters 2004; 572: 65-8.
64. Williams J, Bogwu J, Oyekan A. The role of the RhoA/Rho-kinase signaling pathway in renal vascular reactivity in endothelial nitric oxide synthase null mice. J Hypertens 2006; 24: 1429-36.
65. Ishikawa Y, Nishikimi T, Akimoto K, Ishimura K, Ono H, Matsuoka H. Long-term administration of rho-kinase inhibitor ameliorates renal damage in malignant hypertensive rats. Hypertension 2006; 47: 1075-83.
66. Versteilen AMG, Korstjens IJM, Musters RJP, Groeneveld ABJ, Sipkema P. Rho kinase regulates renal blood flow by modulating eNOS activity in ischemia-reperfusion of the rat kidney. Am J Physiol Renal Physiol 2006; 291: F606-F611.
67. Grisk O, Schülter T, Reimer N, et al. The Rho kinase inhibitor SAR407899 potently inhibits endothelin-1-induced constriction of renal resistance arteries. J Hypertens 2012; 30: 980-9.
68. Roos MH, Rodijnen WF, Lambalgen AA, Wee PM, Tangelder GJ.: Renal microvascular constriction to membrane depolarization and other stimuli: Pivotal role for rho-kinase. Pflugers Arch-Eur J Physiol 2006; 452: 471-7.
69. Ren Y, D'Ambrosio MA, Garvin JL, Wang H, Carretero OA. Possible mediators of connecting tubule glomerular feedback. Hypertension 2009; 53: 319-23.
70. Wang H, D'Ambrosio MA, Garvin JL, Ren Y, Carretero OA. Connecting tubule glomerular feedback mediates acute tubuloglomerular feedback resetting. Am J Physiol Renal Physiol 2012; 302: F1300-F1304.
71. Riteau N, Baron L, Villeret B, et al. ATP release and purinergic signaling: A common pathway for particle-mediated inflammasome activation. Cell Death Dis 2012; 3: e403; doi: 10.1038/cddis.2012.144.
72. Manohar M, Hirsh MI, Chen Y, Woehrle T, Karande AA, Junger WG. ATP release and autocrine signaling through P2X4 receptors regulate γδ T cell activation. J Leukoc Biol 2012; 92: 787-94.
73. Lazarowski ER. Vesicular and conductive mechanisms of nucleotide release. Purinergic Signal 2012; 8: 359-73.
74. Suadicani SO, Iglesias R, Wang J, Dahl G, Spray DC, Scemes E. ATP signaling is deficient in cultured pannexin1-null mouse astrocytes. Glia 2012; 60: 1106-16.
75. Xia J, Lim JC, Lu W, et al. Neurons respond directly to mechanical deformation with pannexin-mediated ATP release and autostimulation of P2X7 receptors. J Physiol (Lond) 2012; 590: 2285-304.
76. Sabirov RZ, Okada Y. ATP release via anion channels. Purinergic Signal 2005; 1: 311-28.
77. Li C, Ramjeesingh M, Bear CE. Purified cystic fibrosis transmembrane conductance regulator (CFTR) does not function as an ATP channel. J Biol Chem 1996; 271: 11623-6.
78. Sabirov RZ, Okada Y. The maxi-anion channel: a classical channel playing novel roles through an unidentified molecular entity. J Physiol Sci 2009; 59: 3-21.
79. Wagner C. Function of connexins in the renal circulation. Kidney Int 2008; 73: 547-55.
80. Nishiyama A, Majid DSA, Walker M, III, Miyatake A, Navar LG. Renal interstitial ATP responses to changes in arterial pressure during alterations in tubuloglomerular feedback activity. Hypertension 2001; 37: 753-9.
81. Nishiyama A, Majid DSA, Taher KA, Miyatake A, Navar LG. Relation between renal interstitial ATP concentrations and autoregulation-mediated changes in renal vascular resistance. Circ Res 2000; 86: 656-62.
82. Inscho EW, Ohishi K, Navar LG. Effects of ATP on pre-and postglomerular juxtamedullary microvasculature. Am J Physiol Renal,Fluid Electrolyte Physiol 1992; 263: F886-F893.
83. Bell PD, Lapointe J-Y, Sabirov R, et al. Macula densa cell signaling involves ATP release through a maxi anion channel. Proc Natl Acad Sci USA 2003; 100: 4322-7.
84. Bell PD, Lapointe JY, Peti-Peterdi J. Macula densa cell signaling. Ann Rev Physiol 2003; 65: 481-500.
85. Liu R, Bell PD, Peti-Peterdi J, Kovacs G, Johansson A, Persson AEG. Purinergic receptor signaling at the basolateral membrane of macula densa cells. J Am Soc Nephrol 2002; 13: 1145-51.
86. Cotrina ML, Lin JHC, Alves-Rodrigues A, et al. Connexins regulate calcium signaling by controlling ATP release. Proc Natl Acad Sci USA 1998; 95: 15735-40.
87. Hanner F, Sorensen CM, Holstein-Rathlou NH, Peti-Peterdi J. Connexins and the kidney. Am J Physiol Regul Integr Comp Physiol 2010; 298: R1143-R1155.
88. Faigle M, Seessle J, Zug S, El-Kasmi KC, Eltzschig HK. ATP release from vascular endothelia occurs across CX43 hemichannels and is attenuated during hypoxia. PLoS One 2013; 3: e2801.
89. Wagner C, De Wit C, Kurtz L, Grunberger C, Kurtz A, Schweda F. Connexin40 is essential for the pressure control of renin synthesis and secretion. Circ Res 2007; 100: 556-63.
90. Allen MJ, Gemel J, Beyer EC, Lal R. Atomic force microscopy of connexin40 gap junction hemichannels reveals calcium-dependent three-dimensional molecular topography and open-closed conformations of both the extracellular and cytoplasmic faces. J Biol Chem 2011; 286: 22139-46.
91. Sipos A, Vargas SL, Toma I, Hanner F, Willecke K, Peti-Peterdi J. Connexin 30 deficiency impairs renal tubular ATP release and pressure natriuresis. J Am Soc Nephrol 2009; 20: 1724-32.
92. Li L, Mizel D, Huang YG, et al. Tubuloglomerular feedback and renal function in mice with targeted deletion of the type 1 equilibrative nucleoside transporter. Am J Physiol Renal Physiol 2013; 304: F382-9.
93. Colgan SP, Eltzschig HK, Eckle T, Thompson LF. Physiological roles for ecto-5'-nucleotidase (CD73). Purinergic Signal 2006; 2: 351-60.
94. Satriano J, Wead L, Cardus A, et al. Regulation of ecto-5'-nucleotidase by NaCl and nitric oxide: Potential roles in tubuloglomerular feedback and adaptation. Am J Physiol Renal Physiol 2006; 291: F1078-F1082.
95. Huang DY, Vallon V, Zimmermann H, Koszalka P, Schrader J, Osswald H. Ecto-5'-nucleotidase (CD73)-dependent and-independent generation of adenosine participates in the mediation of tubuloglomerular feedback in vivo. Am J Physiol Renal Physiol 2006; 291: F282-F288.
96. Van Dokkum RP, Alonso-Galicia M, Provoost AP, Jacob HJ, Roman RJ. Impaired autoregulation of renal blood flow in the fawn-hooded rat. Am J Physiol Regul Integr Comp Physiol 1999; 276: R189.
97. Fitzgerald SM, Evans RG, Bergström G, Anderson WP. Renal hemodynamic responses to intrarenal infusion of ligands for the putative angiotensin IV receptor in anesthetized rats. J Cardiovasc Pharmacol 1999; 34: 206-11.
98. Persson PB. Renal blood flow autoregulation in blood pressure control. Curr Opin Nephrol Hypertension 2002; 11: 67-72.
99. Burke M, Pabbidi MR, Fan F, et al. Genetic basis of the impaired renal myogenic response in FHH rats. Am J Physiol Renal Physiol 2013; 304(5): F565-77.
100. Guan Z, Fuller BS, Yamamoto T, Cook AK, Pollock JS, Inscho EW. Pentosan polysulfate treatment preserves renal autoregulation in Ang II-infused hypertensive rats via normalization of P2X1 receptor activation. Am J Physiol Renal Physiol 2010; 298: F1276-F1284.
101. Guan Z, Giddens MI, Osmond DA, et al. Immunosuppression preserves renal autoregulatory function and microvascular P2X1 receptor reactivity in Ang II hypertensive rats. Am J Physiol Renal Physiol 2013; 304: F801-7.
102. Arendshorst WJ, Beierwaltes WH. Renal and nephron hemodynamics in spontaneously hypertensive rats. Am J Physiol Renal,Fluid Electrolyte Physiol 1979; 236: F246-F251.
103. Arendshorst WJ. Autoregulation of renal blood flow in spontaneously hypertensive rats. Circ Res 1979; 44: 344-9.
104. Bidani AK, Polichnowski AJ, Loutzenhiser R, Griffin KA. Renal microvascular dysfunction, hypertension and CKD progression. Curr Opin Nephrol Hypertension 2013; 22.
105. Burnstock G. Purinergic regulation of vascular tone and remodelling. Auton Autacoid Pharmacol 2009; 29: 63-72.
106. Booth JW, Tam FW, Unwin RJ. P2 purinoceptors: Renal pathophysiology and therapeutic potential. Clin Nephrol 2012; 78: 154-63.
107. Wildman SSP, Marks J, Turner CM, et al. Sodium-dependent regulation of renal amiloride-aensitive currents by apical P2 receptors. J Am Soc Nephrol 2008; 19: 731-42.
108. Wildman SSP, Boone M, Peppiatt-Wildman CM, et al. Nucleotides downregulate aquaporin 2 via activation of apical P2 receptors. J Am Soc Nephrol 2009; 20: 1480-90.
109. Vekaria RM, Unwin RJ, Shirley DG. Intraluminal ATP concentrations in rat renal tubules. J Am Soc Nephrol 2006; 17: 1841-7.
110. Turner CM, Vonend O, Chan C, Burnstock G, Unwin RJ. The pattern of distribution of selected ATP-sensitive P2 receptor subtypes in normal rat kidney: an immunohistological study. Cells Tissues Organs 2003; 175: 105-17.
111. Schwiebert EM, Zsembery A. Extracellular ATP as a signaling molecule for epithelial cells. Biochimica et Biophysica Acta (BBA)-Biomembranes 2003; 1615: 7-32.
112. Bailey MA, Turner CM, Hus-Citharel A, et al. P2Y receptors present in the native and isolated rat glomerulus. Nephron Physiol 2004; 96: 79-90.
113. Guan Z, Inscho EW. Role of adenosine 5'-triphosphate in regulating renal microvascular function and in hypertension. Hypertension 2011; 58: 333-40.
114. Rieg T, Bundey RA, Chen Y, et al. Mice lacking P2Y2 receptors have salt-resistant hypertension and facilitated renal Na+ and water reabsorption. FASEB J 2007; 21: 3717-26.
115. Mulryan K, Gitterman DP, Lewis CJ, et al. Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors. Nature 2000; 403: 86-9.
116. Yamamoto K, Sokabe T, Matsumoto T, et al. Impaired flowdependent control of vascular tone and remodeling in P2X4-deficient mice. Nat Med 2006; 12: 133-7.
117. Graciano ML, Nishiyama A, Jackson K, et al. Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension. Am J Physiol Renal Physiol 2008; 294: F161-F169.
118. Fürstenau CR, Ramos DB, Vuaden FC, et al. l-NAME-treatment alters ectonucleotidase activities in kidney membranes of rats. Life Sci 2010; 87: 325-32.
119. Ji X, Hirokawa G, Weng H, Hirua Y, Takahashi R, Iwai N. P2X7 receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats. Hypertens Res 2012; 35: 173-9.
120. Vonend O, Turner CM, Chan CM, et al. Glomerular expression of the ATP-sensitive P2X receptor in diabetic and hypertensive rat models. Kidney Int 2004; 66: 157-66.
121. Zhao X, Cook AK, Field M, et al. Impaired Ca2+ signaling attenuates P2X receptor-mediated vasoconstriction of afferent arterioles in angiotensin II hypertension. Hypertension 2005; 46: 562-8.
122. Inscho EW, Cook AK, Clarke A, Zhang S, Guan Z. P2X1 receptormediated vasoconstriction of afferent arterioles in angiotensin II infused hypertensive rats fed a high-salt diet. Hypertension 2011; 57: 780-7.
123. Palomino-Doza J, Rahman TJ, Avery PJ, et al. Ambulatory blood pressure is associated with polymorphic variation in P2X receptor genes. Hypertension 2008; 52: 980-5.
124. Wang Z, Nakayama T, Sato N, et al. The purinergic receptor P2Y, G-protein coupled, 2 (P2RY2) gene associated with essential hypertension in Japanese men. J Hum Hypertens 2010; 24: 327-35